PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision

HIV Clinical Trial

Official title:

PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03175094
• Other study ID #: 1407014291
• Secondary ID: K23DA033858
• Status: Completed
• Phase: N/A
• Start date: March 3, 2015
• Est. completion date: November 10, 2017

Study information

• Verified date: August 2021
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

After enrollment, participants will be randomized to either receive the intervention (treatment) from trained health educators or undergo observation as usual (control group). Randomization will be stratified by HIV serostatus. A control group is appropriate because participants will still receive services offered through probation and will be offered the intervention after completion of the trial. Subjects will be paid, not for participating in the intervention, but for providing research assessments. The newly adapted intervention will be delivered over no more than a 3-month period (it will be shorter if the adaptation process is supportive). Baseline assessments will assess the pre-intervention period. The 3-month assessment will be the end-of-intervention effects and the post-intervention assessments will be at 6, 9 and 12 months. HIV prevention knowledge will be assessed based on quizzes used previously for HHRP+; though final quiz content will depend on final selected materials for the intervention. Subjects will be followed for 12 months with assessments by trained research assistants.

Description:

The aim of this study is to adapt and pilot test the Holistic Health Recovery Program for women with and at risk for HIV (HHRP+), a CDC evidence-based secondary HIV prevention intervention, that will serve as a framework to optimize HIV treatment outcomes and reduce HIV-associated risk for women under correctional community supervision.

Hypotheses

1. It will be feasible to recruit and retain HIV+ and at-risk women under community correctional supervision in the pilot study.

2. Using the ADAPT-ITT methods, we will be able to adequately adapt HHRP+ for HIV-infected and at-risk women under community supervision.

3. The adapted intervention will be feasible to implement and acceptable to participants.

4. The adapted intervention will produce higher measureable preliminary effects on HIV-focused treatment outcomes in the intervention group compared with the control group.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: November 10, 2017
• Est. primary completion date: November 10, 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age =18 years old

• female

• have laboratory confirmed HIV OR are at-risk for HIV (ever injected drugs, ever engaged in commercial sex work, were incarcerated in prison or jail within the past 2 years, had condomless sex with an HIV+ partner or partner whose HIV status is unknown in the past 90 days, or had a diagnosed sexually transmitted infection in the past 90 days),

• and are under or anticipating transfer to probation.are either a) sentenced to probation or on intensive pretrial supervision by a probation officer; b) sentenced to parole; or c) incarcerated in jail or prison in the prior 60 days.

Potential participants will be excluded

Exclusion Criteria:

• unable or unwilling to provide informed consent,

• have <3 months of remaining scheduled supervision term,

• or are threatening to staff

Related Conditions & MeSH terms

• HIV

Intervention

Behavioral:
• Holistic Health Recovery Program for HIV+
Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles. The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).

Locations

Country	Name	City	State
United States	Yale AIDS Program	New Haven	Connecticut

Sponsors (2)

Lead Sponsor	Collaborator
Yale University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in HIV knowledge from baseline	HIV knowledge quiz with scores ranging from 0-100, a higher score indicating better knowledge	3 months
Secondary	Change in Sex-related risk behaviors over time	NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)	baseline, 6 months, 12 months
Secondary	Change in Injection-related risk behaviors over time	NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)	baseline, 6 months, 12 months